Le Lézard
Classified in: Health, Science and technology
Subject: Contract/Agreement

La Jolla Institute for Immunology and RevolKa started a Research Collaboration


RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a research collaboration to create antigens for the next-generation vaccines to deliver innovative solutions to unmet medical need in infectious diseases. RevolKa has a robust directed protein evolution technology integrated with artificial intelligence (AI), called aiProtein®. LJI and RevolKa will synergize LJI's deep knowledge of immunology and RevolKa's power of AI-driven protein engineering. Details of this collaboration and financial terms were not disclosed.

About aiProtein® Technology

RevolKa's proprietary technology, aiProtein® is an AI-assisted directed evolution of proteins. Naturally occurring protein is a linear polymer of amino acids and their derivatives, which folds into a tertial structure through internal complex atomic interactions to show biological function. Proteins have evolved to biologically functional molecules over hundreds of millions of years. The relationship between protein sequence, structure, and function in those highly functioned molecules remains poorly understood to rationally design a protein sequence for a particular function. Our AI engine is trained with sequence-function relationship data to statistically predict sequences for an evolved protein function. Furthermore, aiProtein® can evolve more than two functions simultaneously. This technology is a powerful and cost-effective tool for the creation of novel and highly-optimized proteins for pharmaceutical and industrial uses.

About RevolKa Ltd.

RevolKa is a venture-backed biotechnology company founded in April 2021 by academic and industry experts in biotechnology and artificial intelligence. Our mission is to create novel proteins useful for therapeutics and industries by using our own proprietary technology platform, aiProtein® to contribute to human well-being. The name "RevolKa" is derived from the Latin word for evolution, "evolutio" and the Ainu (an indigenous Japanese people) word for raise, "reska". RevolKa's headquarters are located in Tokyo, Japan with laboratories located in Sendai. The company's investors include D3 LLC, DEEPCORE Inc., Tohoku University Venture Partners, and SBI investment Co., Ltd. For more information, visit https://www.revolka.com/en/.

About La Jolla Institute for Immunology

The La Jolla Institute for Immunology is dedicated to understanding the intricacies and power of the immune system to that we may apply to that knowledge to promote human health and prevent a wide range of diseases. Since its founding in 1988 as an independent, nonprofit research organization, the Institute has made numerous advances leading towards its goal: Life without Disease®. For more information, visit https://www.lji.org/.


These press releases may also interest you

at 11:20
Pudgy Penguins, the brand development company behind the series of globally recognized Pudgy Penguins characters, and next-generation gaming technology studio Mythical Games today announced a partnership to create a unique web3-enabled mobile video...

at 11:20
Liberty Latin America Ltd. ("Liberty Latin America", "LLA", or "Company") announces the publication of its Environment, Social Impact, and Corporate Governance (ESG) report, showcasing the meaningful strides the Company has made in its commitment to...

at 11:18
USA News Group ? The current global food security situation is generating calls for international collaboration and strategies. A recent example titled The Case for U.S.-China Cooperation on Climate-Smart from the Center for Strategic & International...

at 11:18
USA News Group News Commentary ? The use of artificial intelligence is on the rise, with the advertising and marketing sector gaining some of the most benefits. Analysts are already projecting major gains, with Statista projecting advertising...

at 11:15
"I wanted to provide vehicle owners with a much easier and safer means of performing battery replacements," said an inventor, from Palmdale, Calif., "so I invented the CASH SPENT WISELY BATTERY. My design allows you to temporarily deactivate the...

at 11:15
One of the most scientifically pioneering health and wellness brands is focusing its investment in the Qualia brand to reflect its growing scope of products and appeal to broader audiences....



News published on and distributed by: